MHRA Offers Medtechs Extra Transition Time For UK Regulatory System Compliance
UK regulator to allow three- and five-year transitions for CE-marked devices and diagnostics
Executive Summary
26 June saw the release finally of the UK government’s official response to the MHRA’s 2021 consultation on its post-Brexit medical devices regulatory framework. The considered response, held up by political and internal timing issues, represents an implementation plan for reform of the system. Crucially it allows industry extra compliance time.